Bristol-Myers Squibb logo

Bristol-Myers Squibb

North America, New York, United States, New York

Description

Bristol-Myers Squibb engages in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals.

Investor Profile

Bristol-Myers Squibb has backed more than 101 startups, with 13 new investments in the last 12 months alone. The firm has led 32 rounds, about 32% of its total and boasts 16 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A, Grant rounds (top funding stages).
  • Majority of deals are located in United States, United Kingdom, Germany.
  • Strong thematic focus on Biotechnology, Health Care, Therapeutics.
  • Led 4 rounds in the past year.

Stage Focus

  • Series B (32%)
  • Series A (21%)
  • Grant (16%)
  • Series C (14%)
  • Post Ipo Equity (6%)
  • Series Unknown (4%)
  • Series D (3%)
  • Corporate Round (3%)
  • Series G (1%)
  • Debt Financing (1%)

Country Focus

  • United States (72%)
  • United Kingdom (10%)
  • Germany (3%)
  • France (3%)
  • Denmark (2%)
  • Switzerland (2%)
  • India (2%)
  • Brazil (2%)
  • Israel (2%)
  • Spain (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Life Science
  • Biopharma
  • Health Diagnostics
  • Oncology
  • Artificial Intelligence (Ai)
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Bristol-Myers Squibb frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 7
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 6
Pfizer Venture Investments
North America, New York, United States, New York
Co-Investments: 7
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 5
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 12
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 9
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 13
CH
North America, New York, United States, New York
Co-Investments: 7
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 10
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 8

Which angels does Bristol-Myers Squibb often collaborate with?

Shared Deals: 1
RA
Europe, Rostov, Russian Federation, Novaya
Shared Deals: 1

What are some of recent deals done by Bristol-Myers Squibb?

BMS - Autoimmune Disease Drugs Business develops new therapies for autoimmune diseases.

MedicalTherapeutics
Series AJul 28, 2025
Amount Raised: $300,000,000
Dispatch Bio

Philadelphia, Pennsylvania, United States

Dispatch Bio helps create a world where all cancer patients can be cured.

BiotechnologyHealth CareTherapeutics
Series AJul 23, 2025
Amount Raised: $216,000,000
GlycoEra

Schlieren, Zurich, Switzerland

GlycoEra is a biotechnology research company that produces extracellular protein degraders for the treatment of autoimmune diseases.

BiotechnologyHealth CareMedical
Series BMay 27, 2025
Amount Raised: $130,000,000
Be Biopharma

Cambridge, Massachusetts, United States

Be Biopharma develops engineered B cell medicines for serious genetic diseases.

BiopharmaBiotechnologyPharmaceutical
Series CJan 15, 2025
Amount Raised: $92,000,000
Light Horse Therapeutics

San Diego, California, United States

Light Horse Therapeutics is a small molecule drug discovery, pioneering to target that causes disabling and life-threatening diseases.

Biotechnology
Series AJan 9, 2025
Amount Raised: $62,000,000
Bridgeway Behavioral Health Services

Elizabeth, Colorado, United States

Bridgeway is an NJ State licensed nonprofit organization providing services to youth and adults experiencing mental health conditions.

Health CareMental Health
GrantDec 18, 2024
Nuvig Therapeutics

Redwood City, California, United States

Nuvig Therapeutics is a biotechnology company developing therapies to induce natural mechanisms to restore immune homeostasis.

BiotechnologyHealth CareTherapeutics
Series BDec 5, 2024
Amount Raised: $161,000,000
Be Biopharma

Cambridge, Massachusetts, United States

Be Biopharma develops engineered B cell medicines for serious genetic diseases.

BiopharmaBiotechnologyPharmaceutical
Series UnknownOct 22, 2024
Amount Raised: $82,000,000
Prime Medicine

Cambridge, Massachusetts, United States

Prime Medicine operates as a biotechnology company that delivers the promise of gene editing using Prime Editing.

BiotechnologyGeneticsLife ScienceMedical
Corporate RoundSep 30, 2024
Amount Raised: $55,000,000
Aktis Oncology

Boston, Massachusetts, United States

Aktis Oncology is a biotechnology company that designs and develops novel class radiopharmaceuticals.

BiotechnologyHealth CareLife ScienceOncology
Series BSep 30, 2024
Amount Raised: $175,000,000